1. Home
  2. AOSL vs ARQT Comparison

AOSL vs ARQT Comparison

Compare AOSL & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AOSL
  • ARQT
  • Stock Information
  • Founded
  • AOSL 2000
  • ARQT 2016
  • Country
  • AOSL United States
  • ARQT United States
  • Employees
  • AOSL N/A
  • ARQT N/A
  • Industry
  • AOSL Semiconductors
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • AOSL Technology
  • ARQT Health Care
  • Exchange
  • AOSL Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • AOSL 1.0B
  • ARQT 1.1B
  • IPO Year
  • AOSL 2010
  • ARQT 2020
  • Fundamental
  • Price
  • AOSL $34.08
  • ARQT $13.02
  • Analyst Decision
  • AOSL Buy
  • ARQT Strong Buy
  • Analyst Count
  • AOSL 3
  • ARQT 6
  • Target Price
  • AOSL $38.67
  • ARQT $17.00
  • AVG Volume (30 Days)
  • AOSL 747.1K
  • ARQT 2.3M
  • Earning Date
  • AOSL 02-05-2025
  • ARQT 02-25-2025
  • Dividend Yield
  • AOSL N/A
  • ARQT N/A
  • EPS Growth
  • AOSL N/A
  • ARQT N/A
  • EPS
  • AOSL N/A
  • ARQT N/A
  • Revenue
  • AOSL $666,399,000.00
  • ARQT $138,708,000.00
  • Revenue This Year
  • AOSL $5.32
  • ARQT $217.37
  • Revenue Next Year
  • AOSL $6.62
  • ARQT $55.64
  • P/E Ratio
  • AOSL N/A
  • ARQT N/A
  • Revenue Growth
  • AOSL 4.12
  • ARQT 182.84
  • 52 Week Low
  • AOSL $19.38
  • ARQT $6.99
  • 52 Week High
  • AOSL $53.29
  • ARQT $16.20
  • Technical
  • Relative Strength Index (RSI)
  • AOSL 40.45
  • ARQT 50.16
  • Support Level
  • AOSL $33.39
  • ARQT $11.13
  • Resistance Level
  • AOSL $37.37
  • ARQT $13.62
  • Average True Range (ATR)
  • AOSL 3.24
  • ARQT 1.04
  • MACD
  • AOSL -0.33
  • ARQT 0.08
  • Stochastic Oscillator
  • AOSL 5.20
  • ARQT 67.26

About AOSL Alpha and Omega Semiconductor Limited

Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: